Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Transplantation and Cellular Therapy
|
November 17, 2021
Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients
Jeremy D Rubinstein, Sonata Jodele, Daria Heyenbruch, et al.
Frontiers in Oncology
|
March 14, 2022
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant
Audrey M Sigmund, Qiuhong Zhao, Justin Jiang, et al.
Journal of Hematology & Oncology
|
January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
Jorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Leukemia
|
August 1, 2020
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
Michael Heuser, Neil Palmisiano, Ioannis Mantzaris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Leukemia
|
June 7, 2018
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Transplantation and Cellular Therapy
|
April 12, 2021
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Evan C Chen, Shuli Li, Ann-Kathrin Eisfeld, et al.
Therapeutic Innovation & Regulatory Science
|
May 17, 2021
Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial
Len Rosenberg, Hugh Levaux, Ross L Levine, et al.
Cancers
|
February 9, 2021
Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
Nidhi Sharma, Qiuhong Zhao, Bin Ni, et al.
Blood Advances
|
October 1, 2020
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome
Adam S Kittai, David A Bond, Basem William, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Transplantation and Cellular Therapy
|
November 17, 2021
Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients
Jeremy D Rubinstein, Sonata Jodele, Daria Heyenbruch, et al.
Frontiers in Oncology
|
March 14, 2022
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant
Audrey M Sigmund, Qiuhong Zhao, Justin Jiang, et al.
Journal of Hematology & Oncology
|
January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
Jorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Leukemia
|
August 1, 2020
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
Michael Heuser, Neil Palmisiano, Ioannis Mantzaris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Leukemia
|
June 7, 2018
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Transplantation and Cellular Therapy
|
April 12, 2021
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Evan C Chen, Shuli Li, Ann-Kathrin Eisfeld, et al.
Therapeutic Innovation & Regulatory Science
|
May 17, 2021
Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial
Len Rosenberg, Hugh Levaux, Ross L Levine, et al.
Cancers
|
February 9, 2021
Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
Nidhi Sharma, Qiuhong Zhao, Bin Ni, et al.
Blood Advances
|
October 1, 2020
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome
Adam S Kittai, David A Bond, Basem William, et al.
Page
of 5